Pharmalytics
The Pharmalytics quarterly reports provide curated knowledge and in-depth market insights into key trends, ecosystem strategies, and innovations shaping the global pharmaceutical logistics landscape. Designed for industry leaders and decision-makers, our Pharma.Aero exclusive reports deliver actionable intelligence to help you navigate a rapidly evolving market and make informed strategic choices.
Headlines of Latest Issue (Q1 – 2025)
Pharma.Aero members, read the full exclusive report in the Member Area of our website here.
-
Global Trade and the Erosion of Predictability: A Pharmaceutical Perspective
-
From Antibiotics to Hormones: A Deep Dive into the EU’s Pharmaceutical Ingredient Imports
-
Mapping Global Veterinary Vaccine Trade: Major Exporters, Importers, and Future Trends
-
Breaking the Cold Chain: How Thermostable Technologies Are Transforming Vaccine Stability and Global Logistic.
-
Pharma & Life Sciences Logistics Markets Q1 2025: Regional mergers, bold integrator moves, and a strategic redirection of supply chains away from geopolitical risk zones
Previous Editions
Pharma.Aero members, read the full exclusive report in the Member Area of our website here
Pharmalytics - Q4, 2024 Exclusive Report
Pharmalytics - Q3, 2024 Exclusive Report
Pharmalytics – Q4, 2024 Exclusive Report
-
In-Depth Analysis of Europe’s Pharmaceutical Export Growth, Trade Flows, and Key Market Subcategories
-
Key Developments in Pharma Logistics for 2024: Mergers, Technological Advancements, and Geopolitical Impact
-
Disrupting Healthcare: The Digital-to-Consumer Shift and the Role of Smart Hospitals in Advancing Medtech and Pharma Innovation
Pharmalytics – Q3, 2024 Exclusive Report
-
Data & analytics on global product flows through major airports and maritime ports
-
Key insights on supply chain trends, including sustainability, innovation, and regulatory shifts
-
Updates on new product designs and their impact on logistics
-
A detailed overview of ecosystem developments, including partnerships, digital transformation, and CSR